Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
69.03
+1.29 (1.90%)
At close: Apr 24, 2026, 4:00 PM EDT
69.00
-0.03 (-0.04%)
After-hours: Apr 24, 2026, 7:43 PM EDT
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,239,853
Market Cap
3.47B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Travere Therapeutics | 497 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
ORKA News
- 6 hours ago - Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 - GlobeNewsWire
- 6 weeks ago - Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Oruka Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Oruka Therapeutics to Participate in Multiple Upcoming Conferences - GlobeNewsWire
- 3 months ago - Oruka Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 - GlobeNewsWire
- 3 months ago - Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Oruka Therapeutics Announces New Board Member and Board Transition - GlobeNewsWire